Published in Stroke on April 10, 2008
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
Neuroplasticity in the context of motor rehabilitation after stroke. Nat Rev Neurol (2011) 1.45
Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci (2012) 1.04
Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics (2009) 1.03
Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing. J Cereb Blood Flow Metab (2010) 1.02
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med (2009) 1.01
Aging of the subventricular zone neural stem cell niche. Aging Dis (2011) 1.00
A systematic review and meta-analysis of buyang huanwu decoction in animal model of focal cerebral ischemia. Evid Based Complement Alternat Med (2013) 0.98
Methodological quality of preclinical stroke studies is not required for publication in high-impact journals. J Cereb Blood Flow Metab (2010) 0.98
G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS One (2011) 0.95
Growth factors in ischemic stroke. J Cell Mol Med (2009) 0.94
Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke. J Neuroinflammation (2014) 0.88
Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia. Exp Transl Stroke Med (2010) 0.88
The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs. J Am Assoc Lab Anim Sci (2015) 0.86
Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes. J Leukoc Biol (2010) 0.86
Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial. PLoS One (2011) 0.86
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Sci Rep (2015) 0.86
Where will the next generation of stroke treatments come from? PLoS Med (2010) 0.84
Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial. PLoS One (2011) 0.83
Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study. Stroke Res Treat (2011) 0.82
Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats. Front Cell Neurosci (2014) 0.80
Synergetic effects of granulocyte-colony stimulating factor and cognitive training on spatial learning and survival of newborn hippocampal neurons. PLoS One (2009) 0.80
Effect of combination therapy using hypothermia and granulocyte colony-stimulating factor in a rat transient middle cerebral artery occlusion model. Iran Biomed J (2014) 0.76
Concurrent use of granulocyte-colony stimulating factor with repetitive transcranial magnetic stimulation did not enhance recovery of function in the early subacute stroke in rats. Neurol Sci (2014) 0.75
Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease. J Anat (2014) 0.75
Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trial. PLoS One (2017) 0.75
Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke. J Immunol Res (2017) 0.75
Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke. Stroke (2008) 0.75
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke (2007) 2.54
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA (2004) 2.04
Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: an analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke (2012) 1.79
Combined laparoscopic-endoscopic resections of colorectal polyps: 10-year experience and follow-up. Surg Endosc (2009) 1.74
Smoking behaviour in European patients with established coronary heart disease. Eur Heart J (2005) 1.58
Comparison between breast volume measurement using 3D surface imaging and classical techniques. Breast (2006) 1.51
Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab (2005) 1.49
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab (2007) 1.39
Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol (2008) 1.30
The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke (2009) 1.29
Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab (2008) 1.26
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J Neurosci (2004) 1.18
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem (2006) 1.16
Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab (2003) 1.13
Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front Neurosci (2010) 1.12
Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke (2010) 1.11
Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart (2010) 1.10
Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens (2011) 1.10
Efficacy of emergency department-initiated tobacco control--systematic review and meta-analysis of randomized controlled trials. Nicotine Tob Res (2012) 1.09
CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther (2010) 1.08
Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke. Stroke (2011) 1.07
TorsinA protects against oxidative stress in COS-1 and PC12 cells. Neurosci Lett (2003) 1.06
New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol Sci (2007) 1.04
Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J (2013) 1.04
Toward a multimodal neuroprotective treatment of stroke. Stroke (2006) 1.04
Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials. Stroke (2006) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics (2009) 1.03
Stroke risk perception among participants of a stroke awareness campaign. BMC Public Health (2007) 1.03
The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain: a characterization of G-CSF-deficient mice. J Neurosci (2009) 1.03
The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res (2009) 1.02
Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time. Stroke (2011) 1.02
Changes in alcohol intake and risk of coronary heart disease and all-cause mortality in the MONICA/KORA-Augsburg cohort 1987-97. Eur J Cardiovasc Prev Rehabil (2004) 1.02
New aspects of breast volume measurement using 3-dimensional surface imaging. Ann Plast Surg (2006) 1.01
Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol (2009) 1.01
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med (2009) 1.01
Neuronal co-expression of EGFP and beta-galactosidase in mice causes neuropathology and premature death. Neurobiol Dis (2004) 1.00
Methodological quality of preclinical stroke studies is not required for publication in high-impact journals. J Cereb Blood Flow Metab (2010) 0.98
Discrepancy between theoretical knowledge and real action in acute stroke: self-assessment as an important predictor of time to admission. Neurol Res (2007) 0.98
Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing. Gastroenterology (2007) 0.98
An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol (2006) 0.98
Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol (2006) 0.98
Carbon dioxide versus room air for natural orifice transluminal endoscopic surgery (NOTES) and comparison with standard laparoscopic pneumoperitoneum. Gastrointest Endosc (2010) 0.97
Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant (2011) 0.97
Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res (2008) 0.96
Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region. Dtsch Arztebl Int (2012) 0.96
KIBRA (KIdney/BRAin protein) regulates learning and memory and stabilizes Protein kinase Mζ. J Neurochem (2013) 0.95
Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice. PLoS One (2011) 0.95
The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury. J Neurochem (2010) 0.95
G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS One (2011) 0.95
Verge: a novel vascular early response gene. J Neurosci (2004) 0.94
Electromagnetic catheter navigation during bronchoscopy: validation of a novel method by conventional fluoroscopy. Chest (2005) 0.94
The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro. BMC Neurosci (2007) 0.94
Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort. Diabetol Metab Syndr (2011) 0.94
Comparison of transgastric access techniques for natural orifice transluminal endoscopic surgery. Gastrointest Endosc (2008) 0.93
Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom? Behav Brain Res (2008) 0.93
Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS One (2010) 0.92
Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J (2003) 0.91
Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol (2012) 0.90
Erythropoietin for stroke treatment: dead or alive? Crit Care (2011) 0.90
Turn-over of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2- or double knockout mice. Exp Neurol (2009) 0.90
The impact of lesion location and lesion size on poststroke infection frequency. J Neurol Neurosurg Psychiatry (2009) 0.89
Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia. Exp Neurol (2009) 0.89
How to weight chronic diseases in multimorbidity indices? Development of a new method on the basis of individual data from five population-based studies. J Clin Epidemiol (2012) 0.89
Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Acta Neuropathol (2006) 0.89
Radon epidemiology: continuous and categorical trend estimators when the exposure distribution is skewed and outliers may be present. J Toxicol Environ Health A (2006) 0.89
Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas. J Pathol (2005) 0.89
Optimal fluorescein dose for intravenous application in miniprobe-based confocal laser scanning microscopy in pigs. J Biophotonics (2010) 0.89
Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia. Exp Transl Stroke Med (2010) 0.88
The receptor for granulocyte-colony stimulating factor (G-CSF) is expressed in radial glia during development of the nervous system. BMC Dev Biol (2008) 0.88
Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. Brain (2012) 0.88
Lung cancer mortality and carbon black exposure: a nested case-control study at a German carbon black production plant. J Occup Environ Med (2006) 0.88
Glycogen synthase kinase 3beta (GSK3beta) regulates differentiation and proliferation in neural stem cells from the rat subventricular zone. J Proteome Res (2007) 0.88
Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study. Exp Neurol (2004) 0.87
Susceptibility genes and progression in age-related maculopathy: a study of single eyes. Invest Ophthalmol Vis Sci (2009) 0.87
The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia. BMC Genomics (2007) 0.87